Display options
Cite
Bendsen NT, Chabanova E, Thomsen HS, et al. Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women. Nutr Diabetes. 2011;1:e4doi: 10.1038/nutd.2010.4.
Bendsen, N. T., Chabanova, E., Thomsen, H. S., Larsen, T. M., Newman, J. W., Stender, S., Dyerberg, J., Haugaard, S. B., & Astrup, A. (2011). Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women. Nutrition & diabetes, 1e4. https://doi.org/10.1038/nutd.2010.4
Bendsen, N T, et al. "Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women." Nutrition & diabetes vol. 1 (2011): e4. doi: https://doi.org/10.1038/nutd.2010.4
Bendsen NT, Chabanova E, Thomsen HS, Larsen TM, Newman JW, Stender S, Dyerberg J, Haugaard SB, Astrup A. Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women. Nutr Diabetes. 2011 Jan 31;1:e4. doi: 10.1038/nutd.2010.4. PMID: 23154296; PMCID: PMC3302130.
Copy Download .nbib Format: NLM
Share it on

Nutr Diabetes. 2011 Jan 31;1:e4. doi: 10.1038/nutd.2010.4.

Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women.

Nutrition & diabetes

N T Bendsen, E Chabanova, H S Thomsen, T M Larsen, J W Newman, S Stender, J Dyerberg, S B Haugaard, A Astrup

Affiliations

  1. Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark.

PMID: 23154296 PMCID: PMC3302130 DOI: 10.1038/nutd.2010.4

Abstract

BACKGROUND: Intake of industrially produced trans fatty acids (TFAs) is, according to observational studies, associated with an increased risk of cardiovascular disease, but the causal mechanisms have not been fully elucidated. Besides inducing dyslipidemia, TFA intake is suspected to promote abdominal and liver fat deposition.

OBJECTIVE: We examined the effect of a high intake of TFA as part of an isocaloric diet on whole-body, abdominal and hepatic fat deposition, and blood lipids in postmenopausal women.

METHODS: In a 16-week double-blind parallel intervention study, 52 healthy overweight postmenopausal women were randomized to receive either partially hydrogenated soybean oil providing 15.7 g day(-1) of TFA or a control oil with mainly oleic and palmitic acid. Before and after the intervention, body composition was assessed by dual-energy X-ray absorptiometry, abdominal fat by magnetic resonance (MR) imaging, and liver fat by (1)H MR spectroscopy.

RESULTS: Compared with the control fat, TFA intake decreased plasma high-density lipoprotein (HDL)-cholesterol by 10%, increased low-density lipoprotein (LDL)-cholesterol by 18% and resulted in an increased LDL/HDL-cholesterol ratio (baseline adjusted mean (95% CI) difference between diet groups 0.41 (0.22; 0.60); P<0.001). TFA tended to increase the body fat (0.46 (-0.20; 1.17) kg; P=0.16) and waist circumference (1.1 (-0.1; 2.4) cm; P=0.08) more than the control fat, whereas neither abdominal nor liver fat deposition was affected by TFA.

CONCLUSION: The adverse effect of dietary TFA on cardiovascular disease risk involves induction of dyslipidemia, and perhaps body fat, whereas weight gain-independent accumulation of ectopic fat could not be identified as a contributory factor during short-term intake.

References

  1. Obesity (Silver Spring). 2007 Apr;15(4):967-76 - PubMed
  2. Eur J Clin Nutr. 2009 Jun;63(6):808-11 - PubMed
  3. Eur J Clin Nutr. 2007 Aug;61(8):1004-10 - PubMed
  4. J Magn Reson Imaging. 2009 Aug;30(2):444-8 - PubMed
  5. Br J Nutr. 2003 May;89(5):631-9 - PubMed
  6. Obesity (Silver Spring). 2009 Jun;17(6):1200-7 - PubMed
  7. Eur J Clin Nutr. 2009 May;63 Suppl 2:S22-33 - PubMed
  8. J Clin Endocrinol Metab. 2009 Jan;94(1):50-5 - PubMed
  9. Obesity (Silver Spring). 2007 Jul;15(7):1675-84 - PubMed
  10. Am J Clin Nutr. 2007 Feb;85(2):362-8 - PubMed
  11. J Nutr. 2009 Jul;139(7):1347-52 - PubMed
  12. Lancet. 2007 Dec 1;370(9602):1829-39 - PubMed
  13. World J Gastroenterol. 2008 Jun 14;14(22):3476-83 - PubMed
  14. N Engl J Med. 2006 Apr 13;354(15):1601-13 - PubMed
  15. Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G987-95 - PubMed
  16. Am J Clin Nutr. 2008 Mar;87(3):558-66 - PubMed
  17. J Clin Endocrinol Metab. 2005 May;90(5):2804-9 - PubMed
  18. Diabetologia. 2004 Aug;47(8):1360-9 - PubMed
  19. N Engl J Med. 1999 Jun 24;340(25):1994-8 - PubMed
  20. Clin Chem. 1972 Jun;18(6):499-502 - PubMed
  21. Dig Liver Dis. 2008 Mar;40(3):194-9 - PubMed
  22. Diabetologia. 2002 Mar;45(3):369-77 - PubMed
  23. Am J Clin Nutr. 2004 Aug;80(2):271-8 - PubMed
  24. Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G378-84 - PubMed
  25. Eur J Clin Nutr. 2004 Jul;58(7):1062-70 - PubMed
  26. Int J Obes Relat Metab Disord. 1997 Dec;21(12):1161-6 - PubMed
  27. J Clin Endocrinol Metab. 2009 Oct;94(10):3842-8 - PubMed
  28. J Clin Endocrinol Metab. 2008 Jul;93(7):2702-8 - PubMed
  29. N Engl J Med. 1997 Nov 20;337(21):1491-9 - PubMed
  30. Br J Nutr. 2003 Nov;90(5):887-93 - PubMed
  31. N Engl J Med. 2009 Jul 16;361(3):314-6 - PubMed
  32. Int J Obes Relat Metab Disord. 2003 Feb;27(2):211-8 - PubMed
  33. Am J Clin Nutr. 2009 Oct;90(4):1002-10 - PubMed
  34. J Clin Endocrinol Metab. 2007 Aug;92(8):3326-9 - PubMed
  35. Diabet Med. 2006 May;23(5):469-80 - PubMed
  36. Am J Clin Nutr. 1982 Nov;36(5):936-42 - PubMed
  37. J Am Diet Assoc. 1999 Feb;99(2):166-74; quiz 175-6 - PubMed
  38. Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15430-5 - PubMed
  39. Am J Clin Nutr. 2003 Oct;78(4):719-27 - PubMed

Publication Types